Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:14:34.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:25.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:27.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.7.0 added. A large set of core study metadata, including investigators and locations, eligibility criteria, and study record details, was removed.
    Difference
    19%
    Check dated 2026-09-20T22:10:14.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page adds an NIH grant/contract note to the study identifiers and updates the page revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T21:46:54.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears on the page, replacing the previous v3.6.4, signaling a routine site update.
    Difference
    0.1%
    Check dated 2026-08-09T09:11:22.000Z thumbnail image

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.